BioNexus Gene Lab Corp. completes RM1 million strategic investment in Ascension Innovation Sdn Bhd

KUALA LUMPUR, Malaysia, Aug. 27, 2024 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (NASDAQ: BGLC), an emerging leader in genomic diagnostics and health technology, today announced the successful completion of its RM1 million (approximately USD228k) investment in Ascension Innovation Sdn Bhd (AISB), a pioneering Malaysian healthcare technology company. This strategic investment, executed through BGLC’s wholly-owned subsidiary, MRNA Scientific Sdn Bhd, further solidifies BGLC’s commitment to advancing AI-driven healthcare solutions.

AISB specializes in innovative healthcare technologies, notably through its flagship platform aiCMS, which integrates advanced predictive analytics and AI tools to improve clinical management and patient care. The investment provides BGLC with a significant equity stake in AISB, enabling deeper collaboration between the two companies.